Labcorp Holdings Inc (LH)
238.64
+3.43
(+1.46%)
USD |
NYSE |
Nov 18, 16:00
238.72
+0.08
(+0.03%)
Pre-Market: 20:00
Labcorp Holdings Revenue (TTM): 12.71B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 12.71B |
June 30, 2024 | 12.49B |
March 31, 2024 | 12.30B |
December 31, 2023 | 12.16B |
September 30, 2023 | 12.06B |
June 30, 2023 | 11.87B |
March 31, 2023 | 11.76B |
December 31, 2022 | 12.62B |
September 30, 2022 | 10.76B |
June 30, 2022 | 11.96B |
March 31, 2022 | 12.87B |
December 31, 2021 | 13.14B |
September 30, 2021 | 16.55B |
June 30, 2021 | 16.39B |
March 31, 2021 | 15.32B |
December 31, 2020 | 13.98B |
September 30, 2020 | 12.44B |
June 30, 2020 | 11.47B |
March 31, 2020 | 11.59B |
December 31, 2019 | 11.55B |
September 30, 2019 | 11.39B |
June 30, 2019 | 11.29B |
March 31, 2019 | 11.28B |
December 31, 2018 | 11.33B |
September 30, 2018 | 11.29B |
Date | Value |
---|---|
June 30, 2018 | 11.08B |
March 31, 2018 | 10.74B |
December 31, 2017 | 10.31B |
September 30, 2017 | 9.903B |
June 30, 2017 | 9.696B |
March 31, 2017 | 9.599B |
December 31, 2016 | 9.553B |
September 30, 2016 | 9.514B |
June 30, 2016 | 9.416B |
March 31, 2016 | 9.255B |
December 31, 2015 | 8.680B |
September 30, 2015 | 7.892B |
June 30, 2015 | 7.127B |
March 31, 2015 | 6.374B |
December 31, 2014 | 6.012B |
September 30, 2014 | 5.936B |
June 30, 2014 | 5.846B |
March 31, 2014 | 5.798B |
December 31, 2013 | 5.808B |
September 30, 2013 | 5.777B |
June 30, 2013 | 5.734B |
March 31, 2013 | 5.689B |
December 31, 2012 | 5.671B |
September 30, 2012 | 5.632B |
June 30, 2012 | 5.617B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
10.76B
Minimum
Sep 2022
16.55B
Maximum
Sep 2021
12.80B
Average
12.37B
Median
Revenue (TTM) Benchmarks
Delcath Systems Inc | 22.64M |
Star Equity Holdings Inc | 47.15M |
Exact Sciences Corp | 2.692B |
CytoSorbents Corp | 33.79M |
Progyny Inc | 1.139B |